A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

NCT05335122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: OTX-TIC low dose Travoprost Intracameral Implant
DRUG: OTX-TIC high dose Travoprost Intracameral Implant
DRUG: Durysta, Bimatoprost Intracameral Implant 10 µg

Sponsor

Ocular Therapeutix, Inc.